Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5155)
All Articles published online
|
Nov 26, 2010 (publication date) through Dec 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Biological Chemistry
ISSN
1949-8454
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sato K, Okajima F. Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein. World J Biol Chem 2010; 1(11): 327-337 [PMID: 21537467 DOI: 10.4331/wjbc.v1.i11.327] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8454/full/v1/i11/327.htm |
| Number | Citing Articles |
| 1 |
Joanne T.M. Tan, Martin K.C. Ng, Christina A. Bursill. The role of high-density lipoproteins in the regulation of angiogenesis. Cardiovascular Research 2015; 106(2): 184 doi: 10.1093/cvr/cvv104
|
| 2 |
Yali Yan, Gegentuya Bao, Jingyuan Pei, Ying Cao, Chenyu Zhang, Pengfei Zhao, Yantao Zhang, Alatangaole Damirin. NF-κB and EGFR participate in S1PR3-mediated human renal cell carcinomas progression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022; 1868(7): 166401 doi: 10.1016/j.bbadis.2022.166401
|
| 3 |
Mary G. Sorci-Thomas, Michael J. Thomas. High Density Lipoprotein Biogenesis, Cholesterol Efflux, and Immune Cell Function. Arteriosclerosis, Thrombosis, and Vascular Biology 2012; 32(11): 2561 doi: 10.1161/ATVBAHA.112.300135
|
| 4 |
Steven L. Swendeman, Yuquan Xiong, Anna Cantalupo, Hui Yuan, Nathalie Burg, Yu Hisano, Andreane Cartier, Catherine H. Liu, Eric Engelbrecht, Victoria Blaho, Yi Zhang, Keisuke Yanagida, Sylvain Galvani, Hideru Obinata, Jane E. Salmon, Teresa Sanchez, Annarita Di Lorenzo, Timothy Hla. An engineered S1P chaperone attenuates hypertension and ischemic injury. Science Signaling 2017; 10(492) doi: 10.1126/scisignal.aal2722
|
| 5 |
Michael Maceyka, Kuzhuvelil B. Harikumar, Sheldon Milstien, Sarah Spiegel. Sphingosine-1-phosphate signaling and its role in disease. Trends in Cell Biology 2012; 22(1): 50 doi: 10.1016/j.tcb.2011.09.003
|
| 6 |
F. Poti, M. Simoni, J.-R. Nofer. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P). Cardiovascular Research 2014; 103(3): 395 doi: 10.1093/cvr/cvu136
|
| 7 |
Koichi Sato, Masayuki Tobo, Chihiro Mogi, Naoya Murata, Mie Kotake, Atsushi Kuwabara, Dong-Soon Im, Fumikazu Okajima. Lipoprotein-associated lysolipids are differentially involved in high-density lipoprotein- and its oxidized form-induced neurite remodeling in PC12 cells. Neurochemistry International 2014; 68: 38 doi: 10.1016/j.neuint.2014.02.005
|
| 8 |
Lincheng Zhang, Yutong Dong, Yiran Wang, Wenhui Hu, Shiwu Dong, Yueqi Chen. Sphingosine‐1‐phosphate (S1P) receptors: Promising drug targets for treating bone‐related diseases. Journal of Cellular and Molecular Medicine 2020; 24(8): 4389 doi: 10.1111/jcmm.15155
|
| 9 |
R. Lorenzi, F. Pattou, J.-B. Beuscart, N. Grossin, M. Lambert, P. Fontaine, R. Caiazzo, M. Pigeyre, A. Patrice, M. Daroux, E. Boulanger, S. Dubucquoi. Anti-sRAGE autoimmunity in obesity: Downturn after bariatric surgery is independent of previous diabetic status. Diabetes & Metabolism 2014; 40(5): 356 doi: 10.1016/j.diabet.2014.04.008
|
| 10 |
Evangelia Zvintzou, Eva Xepapadaki, George Skroubis, Victoria Mparnia, Katerina Giannatou, Karim Benabdellah, Kyriakos E. Kypreos. High-Density Lipoprotein in Metabolic Disorders and Beyond: An Exciting New World Full of Challenges and Opportunities. Pharmaceuticals 2023; 16(6): 855 doi: 10.3390/ph16060855
|
| 11 |
Jingjing Liu, Andrew Hsu, Jen-Fu Lee, Daniel E Cramer, Menq-Jer Lee. To stay or to leave: Stem cells and progenitor cells navigating the S1P gradient. World Journal of Biological Chemistry 2011; 2(1): 1-13 doi: 10.4331/wjbc.v2.i1.1
|
| 12 |
Samantha Adamson, Norbert Leitinger. Phenotypic modulation of macrophages in response to plaque lipids. Current Opinion in Lipidology 2011; 22(5): 335 doi: 10.1097/MOL.0b013e32834a97e4
|
| 13 |
Hamish C. Prosser, Martin K.C. Ng, Christina A. Bursill. The role of cholesterol efflux in mechanisms of endothelial protection by HDL. Current Opinion in Lipidology 2012; 23(3): 182 doi: 10.1097/MOL.0b013e328352c4dd
|
| 14 |
Jonathan D. Schofield, Michael France, Basil Ammori, Yifen Liu, Handrean Soran. High-density lipoprotein cholesterol raising. Current Opinion in Cardiology 2013; 28(4): 464 doi: 10.1097/HCO.0b013e328362210d
|
| 15 |
Xunliang Tong, Hui Peng, Donghui Liu, Liang Ji, Chenguang Niu, Jun Ren, Bing Pan, Jianying Hu, Lemin Zheng, Yining Huang. High-density lipoprotein of patients with Type 2 Diabetes Mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate. Cardiovascular Diabetology 2013; 12(1) doi: 10.1186/1475-2840-12-27
|
| 16 |
Shigetomo Fukuhara, Szandor Simmons, Shunsuke Kawamura, Asuka Inoue, Yasuko Orba, Takeshi Tokudome, Yuji Sunden, Yuji Arai, Kazumasa Moriwaki, Junji Ishida, Akiyoshi Uemura, Hiroshi Kiyonari, Takaya Abe, Akiyoshi Fukamizu, Masanori Hirashima, Hirofumi Sawa, Junken Aoki, Masaru Ishii, Naoki Mochizuki. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. Journal of Clinical Investigation 2012; 122(4): 1416 doi: 10.1172/JCI60746
|
| 17 |
Paul N. Hopkins. Molecular Biology of Atherosclerosis. Physiological Reviews 2013; 93(3): 1317 doi: 10.1152/physrev.00004.2012
|
| 18 |
Anouar Hafiane, Jacques Genest. HDL, Atherosclerosis, and Emerging Therapies. Cholesterol 2013; 2013: 1 doi: 10.1155/2013/891403
|
| 19 |
Yan-Yan Liu, Shao-Jun Lin, Yuan-Yuan Chen, Li-Na Liu, Liu-Bin Bao, Lin-Quan Tang, Jing-Song Ou, Zhi-Gang Liu, Xiao-Zhong Chen, Yan Xu, Jun Ma, Anthony T. Chan, Ming Chen, Yun-Fei Xia, Wan-Li Liu, Yi-Xin Zeng, Hai-Qiang Mai, Mu-Sheng Zeng, Jian-Ji Pan, Xing Zhang. High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinoma. Oncotarget 2016; 7(28): 42978 doi: 10.18632/oncotarget.7160
|
| 20 |
Evangelia Zvintzou, Dimitra Sotiria Karampela, Aggeliki Vakka, Eva Xepapadaki, Eleni A. Karavia, Aikaterini Hatziri, Panagiota C. Giannopoulou, Kyriakos E. Kypreos. High density lipoprotein in atherosclerosis and coronary heart disease: Where do we stand today?. Vascular Pharmacology 2021; 141: 106928 doi: 10.1016/j.vph.2021.106928
|
| 21 |
Fumikazu Okajima. From the Glucose Metabolism to the Signal Transduction Study. The KITAKANTO Medical Journal 2017; 67(2): 97 doi: 10.2974/kmj.67.97
|
| 22 |
Aynaz Mihanfar, Hamid Reza Nejabati, Amir Fattahi, Zeinab Latifi, Masoud Pezeshkian, Abbas Afrasiabi, Naser Safaie, Ahmad Reza Jodati, Mohammad Nouri. The role of sphingosine 1 phosphate in coronary artery disease and ischemia reperfusion injury. Journal of Cellular Physiology 2019; 234(3): 2083 doi: 10.1002/jcp.27353
|
| 23 |
Sotirios K Karathanasis, Lita A Freeman, Scott M Gordon, Alan T Remaley. The Changing Face of HDL and the Best Way to Measure It. Clinical Chemistry 2017; 63(1): 196 doi: 10.1373/clinchem.2016.257725
|
| 24 |
Óscar Pérez-Méndez, Héctor González Pacheco, Carlos Martínez-Sánchez, Martha Franco. HDL-cholesterol in coronary artery disease risk: Function or structure?. Clinica Chimica Acta 2014; 429: 111 doi: 10.1016/j.cca.2013.12.001
|
| 25 |
Bodo Levkau. HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications. Frontiers in Pharmacology 2015; 6 doi: 10.3389/fphar.2015.00243
|
| 26 |
Elena M. G. Diarte-Añazco, Karen Alejandra Méndez-Lara, Antonio Pérez, Núria Alonso, Francisco Blanco-Vaca, Josep Julve. Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases. International Journal of Molecular Sciences 2019; 20(24): 6273 doi: 10.3390/ijms20246273
|
| 27 |
Yu Hisano, Timothy Hla. Bioactive lysolipids in cancer and angiogenesis. Pharmacology & Therapeutics 2019; 193: 91 doi: 10.1016/j.pharmthera.2018.07.006
|
| 28 |
Simona Federica Spampinato, Maria Angela Sortino, Salvatore Salomone. New Targets for the Treatment of Hypertension and Associated Diseases. Advances in Pharmacology 2022; 94: 95 doi: 10.1016/bs.apha.2022.02.001
|
| 29 |
Jaya M. Thomas, Tara Sudhadevi, Prathima Basa, Alison W. Ha, Viswanathan Natarajan, Anantha Harijith. The Role of Sphingolipid Signaling in Oxidative Lung Injury and Pathogenesis of Bronchopulmonary Dysplasia. International Journal of Molecular Sciences 2022; 23(3): 1254 doi: 10.3390/ijms23031254
|